GE stock trades at 50.4 times expected 2023 EPS, 25.1 times estimated 2024 earnings of $3.97 and 19.2 times estimated 2025 earnings of $5.20 per share. The stock’s 52-week trading range is $59.93 to $100.47, and GE pays an annual dividend of $0.32 (yield of 0.32%). Total shareholder return for the past 12 months was 40.7%.
GE Healthcare
GE Healthcare Technologies Inc. (NASDAQ: GEHC) began trading on January 3 and joined the S&P 500 index on the same day. Since the spin-off from GE, which retained a 20% stake in the company, shares have added nearly 47%. The health care technology company received FDA approval for its patient monitoring system. Institutional ownership of the stock is around 53%, indicating that the so-called smart money is paying more attention to its growth possibilities.
The number of analysts covering the stock has risen from two in January to seven, and five of those brokerages rate the stock a Buy or Strong Buy. There is also one Sell rating. At a share price of around $85.50, the implied upside based on a median price target of $91.00 is 6.4%. At the high target of $95.00, the upside potential is 11.1%.
Analysts anticipate first-quarter revenue of $4.63 billion, down 6.2% sequentially. EPS are expected to come in at $0.79. For the full 2023 fiscal year, EPS are forecast at $3.72, down 19.6% from a pro forma result of $4.63 in 2022.
GE Healthcare stock trades at 22.9 times expected 2023 EPS, 20.1 times estimated 2024 earnings of $4.23 and 17.3 times estimated 2025 earnings of $4.92 per share. The stock’s 52-week range is $59.93 to $100.47, and GE pays an annual dividend of $0.32 (yield of 0.32%). Total shareholder return for the past 12 months was 40.7%.
The stock’s post-IPO range is $53.00 to $86.88. GE Healthcare does not pay a dividend.
General Motors
General Motors Co. (NYSE: GM) has seen its share price drop by about 20% over the past year, including a dip of 1.2% so far in 2023. That’s better than Ford’s decline of nearly 27%, but far short of Stellantis’s boost of 21.1%.
Earlier this week, the company agreed to pay a fine of $365,000 to settle a discrimination claim filed by the U.S. Department of Justice. In the first quarter, GM sold just over 20,000 EVs in the United States, about double the number rival Ford sold, while Stellantis failed to sell any. The only good news there is that GM’s total was second only to Tesla’s first-quarter total of around 161,000 U.S. sales, even including sales by foreign carmakers, according to Cox Automotive.
Analysts like the company’s prospects. Of 26 brokers covering the stock, 14 have a Buy or Strong Buy rating and another 11 rate it at Hold. At a share price of around $33.20, the upside potential based on a median price target of $45.00 is 26.2%. At the high price target of $86.00, the upside potential is about 159%.
First-quarter revenue is forecast at $39.37 billion, down 8.7% sequentially but up 9.4% year over year. Adjusted EPS are forecast at $1.71, down 19.5% sequentially and by 18.2% year over year. For the full 2023 fiscal year, consensus estimates call for EPS of $6.12, down 19.4%, on revenue of $161.7 billion, up 3.2%.
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
